Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FQGZB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,219
Award facts
- Contract value 100% obligated
- $36,218.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,218.76 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen auto-injectors. The contract, awarded July 18, 2025, with an ultimate completion date of July 21, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and operates as a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026.
This delivery order represents a routine medical supply transaction within AmerisourceBergen's extensive federal contract portfolio supporting military and veteran healthcare systems. Dupixent (dupilumab) is a biologic therapeutic commonly used in the treatment of atopic dermatitis, eczema, and other allergic conditions, and its procurement through DLA reflects the ongoing medical supply needs of the Defense Health Agency and other military healthcare programs. The three-day completion window indicates expedited delivery requirements typical of emergency or critical medical supply needs within the military healthcare system.
Quick answers
Who was awarded contract SPE2DB25FQGZB?
SPE2DB25FQGZB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FQGZB worth?
The government has obligated $36,219 on SPE2DB25FQGZB.
Is contract SPE2DB25FQGZB an order under another contract?
Yes. SPE2DB25FQGZB is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQGZB competed?
The extent of competition for SPE2DB25FQGZB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award